Coagulation factor XI as a novel target for antithrombotic treatment
Circulating microparticles in cardiovascular disease: implications for atherogenesis and atherothrombosis
Thromboxane Antagonism with terutroban in Peripheral Arterial Disease: the TAIPAD study
The minor allele of GP6 T13254C is associated with decreased platelet activation and a reduced risk of recurrent cardiovascular events and mortality: results from the SMILE–Platelets project
Acute and subacute stent thrombosis after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: incidence, predictors and clinical outcome
Haplotype and genotype effects of the F7 gene on circulating factor VII, coagulation activation markers and incident coronary heart disease in UK men
Fifty per cent of patients with pulmonary embolism can be treated as outpatients
Ambulatory management of pulmonary embolism: a pragmatic evaluation
Safety of outpatient treatment in acute pulmonary embolism
Effectiveness of pharmacist-participated warfarin therapy management: a systematic review and meta-analysis
Chronic kidney disease stages 1–3 increase the risk of venous thrombosis
Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient-level meta-analysis
Risk of venous thrombosis in pregnancy among carriers of the factor V Leiden and the prothrombin gene G20210A polymorphisms
A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score
A dose-ranging study evaluating the oral factor Xa inhibitor edoxaban for the prevention of venous thromboembolism in patients undergoing total knee arthroplasty
The expanding menagerie: animal models of hemophilia A
WAG-F8m1Ycb rats harboring a factor VIII gene mutation provide a new animal model for hemophilia A
Factor XIII – an under diagnosed deficiency – are we using the right assays?
Systematic review on the effect of glucocorticoid use on procoagulant, anti-coagulant and fibrinolytic factors
Mechanisms of factor VIIa-catalyzed activation of factor VIII
Factor deficiencies in venom-induced consumption coagulopathy resulting from Australian elapid envenomation: Australian Snakebite Project (ASP-10)
High incidence of tumors in diabetic thrombin activatable fibrinolysis inhibitor and apolipoprotein E double-deficient mice
Secretion and antifibrinolytic function of thrombin-activatable fibrinolysis inhibitor from human platelets
Platelet endothelial cell adhesion molecule-1 regulates collagen-stimulated platelet function by modulating the association of phosphatidylinositol 3-kinase with Grb-2-associated binding protein-1 and linker for activation of T cells
A monopartite sequence is essential for p45 NF-E2 nuclear translocation, transcriptional activity and platelet production
Platelet apoptosis by cold-induced glycoprotein Ibα clustering
A novel mechanism of cytokine release in phagocytes induced by aggretin, a snake venom C-type lectin protein, through CLEC-2 ligation
Standardization of platelet-derived microparticle enumeration by flow cytometry with calibrated beads: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop
Major bleeding as a predictor of mortality in patients with venous thromboembolism: findings from the RIETE Registry
Cilostazol augments the inhibition of platelet aggregation in clopidogrel low-responders
Cytoplasmic stabilities of 3′UTR-polymorphic prothrombin mRNAs
Inflammation does not predispose to bleeding in hemophilia
Join ISTH
Corrigendum